Home
Abstract
My Abstract(s)
Login
ePosters
Back
Final Presentation Format
Rejected
Eposter Presentation
Eposter in PDF Format
Accept format: PDF. The file size should not be more than 5MB
Eposter in Image Format
Accept format: PNG/JPG/WEBP. The file size should not be more than 2MB
Presentation Date / Time
Submission Status
Submitted
Abstract
Abstract Title
Primary Signet-ring Cell Carcinoma of the bladder with neobladder recurrence – A Case Report
Presentation Type
Moderated Poster Abstract
Manuscript Type
Case Study
Abstract Category *
Oncology: Bladder and UTUC
Author's Information
Number of Authors (including submitting/presenting author) *
4
No more than 10 authors can be listed (as per the Good Publication Practice (GPP) Guidelines).
Please ensure the authors are listed in the right order.
Country
Australia
Co-author 1
Divar Vijendran divar_14@hotmail.com Royal North Shore Hospital Urology Sydney Australia *
Co-author 2
Jodie McDonald jodie.Mcdonald2@health.nsw.gov.au Royal North Shore Hospital Urology Sydney Australia -
Co-author 3
Jordan Mann jordan.mann1@health.nsw.gov.au Royal North Shore Hospital Urology Sydney Australia -
Co-author 4
Matthew Winter drmatthewwinter@gmail.com Royal North Shore hospital Urology Sydney Australia -
Co-author 5
-
Co-author 6
-
Co-author 7
-
Co-author 8
-
Co-author 9
-
Co-author 10
-
Co-author 11
-
Co-author 12
-
Co-author 13
-
Co-author 14
-
Co-author 15
-
Co-author 16
-
Co-author 17
-
Co-author 18
-
Co-author 19
-
Co-author 20
-
Abstract Content
Introduction
Primary signet-ring cell carcinoma (SRCC) of the urinary bladder is an extraordinarily rare adenocarcinoma of the bladder with an incidence of less than 0.6% of all bladder malignancy and is typically associated with a poor prognosis.[1] Here, we describe an interesting case of a patient who presented with a recurrence of SRCC in his neobladder with a metastasis to the anterior abdominal rectus muscle who underwent a repeat cystectomy of the neobladder with ileal conduit formation alongside abdominal wall reconstruction using an anterolateral thigh (ATL) flap.
Materials and Methods
A 50-year-old otherwise healthy man who initially presented 5 years ago with painless haematuria was then diagnosed with SRCC and had a robotic cystectomy with neobladder formation in 2020 with histopathology of pT4N2, high grade. On surveillance imaging, local recurrence was identified within his neobladder and the adjacent rectus abdominis in early 2023 where he was treated with Pembrolizumab immunotherapy that would go on for 2 years. In July 2024, a Transurethral resection of Bladder Tumor (TURBT) of the neobladder was performed that found necrotic signet-ring cell carcinoma with deep invasion. He was then commenced on 7 cycles of carboplatin chemotherapy. He had repeat surveillance imaging in October 2024, that noted the tumor to have increased in size to 45x41x47mm and with marginally smaller known metastatic lesion with the right abdominus rectus anterior to neobladder, measuring 40x47x97mm. The failure of systemic therapy that consisted of carboplatin chemotherapy and pembrolizumab immunotherapy led to the planning of a joint case between urology and plastics surgery for a repeat cystectomy of the neobladder and abdominal wall reconstructive surgery using an ATL flap. Patient’s consent was gained. A review of the literature was performed, patient information and clinical media were collected.
Results
The patient was placed in a supine position. A midline laparotomy incision was made. Circumferential dissection of neobladder including the right rectus muscle was aided by bone cutter and nibbler to free off from the pubic bone and sent for en bloc histopathology which showed nil evidence of pubic bone involvement. Bilateral ureters dissected and mobilized. Neobladder pedicle closed with a vascular stapler. Ileal conduit formed using a new 20cm length of terminal ileum with an Echelon stapler. Bowel continuity restored. Routine Bricker anastomosis performed and urostomy brought to skin. The case was handed over to the Plastics team for the right ALT flap abdominal wall reconstruction. The patient was admitted to ICU for routine monitoring and discharged to the ward after 3 days. He underwent an uncomplicated post-operative recovery in hospital and with the help of multidisciplinary teams he was deemed ready for discharge D10 post op. Post-op histopathology returned as SRCC recurrence within the neobladder and a secondary neuroendocrine tumor within the right abdominal rectus muscle with negative margins.
Conclusions
We describe a rare case in which there is recurrence of SRCC within a neobladder with locally advanced disease into the rectus abdominis that was completely resected with clear margins. Due to the scarcity of literature of bladder SRCC in itself, let alone recurrence within a neobladder, this case report aims to give better understanding on potential management options of resectable disease.
Keywords
References 1. Benerjee N, Parmar K, Vaiphei K. Primary signet-ring cell carcinoma of the urinary bladder. Autops Case Rep. 2021 Apr 22;11:e2021264. doi: 10.4322/acr.2021.264. PMID: 33968831; PMCID: PMC8087395.
Figure 1
Figure 1 Caption
Figure 2
Figure 2 Caption
Figure 3
Figure 3 Caption
Figure 4
Figure 4 Caption
Figure 5
Figure 5 Caption
Character Count
0
Vimeo Link
Presentation Details
Session
Date
Time
Presentation Order